ALGS logo

Aligos Therapeutics, Inc. (ALGS)

Profile

Full Name

Aligos Therapeutics, Inc.

Ticker

NASDAQ: ALGS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 16, 2020

Indexes

Not included

Website

https://www.aligos.com

Employees

70

Key Details

Price

$10.20(-6.25%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.94M(-74.60% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.20
    ALGS price is $10.20

    30-Day Relative Volume

    0.72
    ALGS 30-day relative volume is 0.72

    Price Performance

    Price Most recent change

    -6.25%
    ALGS price was down -6.25% on Sep 12, 2025

    Price YTD change

    -74.4%
    ALGS price is down -74.4% since January 1st

    Price 1-year change

    -27.3%
    ALGS price is down -27.3% year-on-year

    Price 3-year change

    -69.78%
    ALGS price is down -69.78% over the past 3 years

    Price Range

    Price All-time high

    $937.75
    ALGS price is currently -98.91% below its historical high of $937.75

    Price 3-year low

    $3.76
    ALGS price is currently +171.28% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $70.90M
    ALGS market capitalization is $70.90 million

    Market cap 3-year change

    +22.69%
    ALGS market capitalization is up +22.69% over the past 3 years

    Market cap All-time high

    $1.28B
    ALGS market capitalization is currently -94.47% below its historical high of $1.28 billion

    Market cap sector rank

    36.89%
    ALGS market capitalization is higher than 36.89% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +117.5%
    ALGS shares outstanding is up +117.5% year-on-year

    Shares Outstanding 3-Year Change

    +305.94%
    ALGS shares outstanding is up +305.94% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.38
    ALGS beta is 2.38

    200-day SMA

    $14.91
    ALGS price is currently -31.60% below its 200-day simple moving average

    50-day SMA

    $9.08
    ALGS price is currently +12.35% above its 50-day simple moving average

    RSI

    52.77
    ALGS 14-day relative strength index is 52.77

    Volume

    0.72
    ALGS 30-day relative volume is 0.72

    ATR

    $0.83
    ALGS average true range is $0.83

    10-day Historical Volatility

    57.46%
    ALGS 10-day historical volatility is 57.46%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.94M
    ALGS annual revenue is $3.94 million

    Revenue Analysts estimate

    $2.29M
    ALGS annual revenue is currently +71.97% higher than the consensus analysts' forecast

    Revenue 1-year change

    -74.6%
    ALGS annual revenue is down -74.6% year-on-year

    Revenue Sector rank

    42.46%
    ALGS annual revenue is higher than 42.46% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    ALGS annual earnings per share is $0.00

    EPS Analysts estimate

    -$7.88
    ALGS annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    ALGS annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.42%
    ALGS annual earnings per share is higher than 82.42% of companies in Healthcare sector

    Profit

    Gross profit

    $1.32M
    ALGS annual gross profit is $1.32 million

    Gross margin

    33.54%
    ALGS annual gross profit margin is 33.54%

    Operating profit

    -$89.15M
    ALGS annual operating income is -$89.15 million

    Operating margin

    -2259.92%
    ALGS annual operating profit margin is -2259.92%

    Net income

    -$131.21M
    ALGS annual net profit is -$131.21 million

    Net margin

    -3326.01%
    ALGS annual net profit margin is -3326.01%

    Expenses

    Total expenses

    $135.16M
    ALGS annual total expenses is $135.16 million

    Operating expenses

    $90.48M
    ALGS annual total operating expenses is $90.48 million

    Cost of goods sold

    $2.62M
    ALGS annual cost of goods sold is $2.62 million

    Selling, general & administrative expenses

    $0.00
    ALGS annual SGA is $0.00

    Depreciation and amortization

    $2.62M
    ALGS annual depreciation & amortization is $2.62 million

    Interest expense

    $0.00
    ALGS annual interest expense is $0.00

    Income tax

    $331.00K
    ALGS annual income tax is $331.00 thousand

    EBIT & EBITDA

    EBIT

    -$89.15M
    ALGS annual earnings before interest & taxes is -$89.15 million

    EBITDA

    -$86.53M
    ALGS annual EBITDA is -$86.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $71.85M
    ALGS annual total assets is $71.85 million

    Non current assets

    $7.95M
    ALGS annual long term assets is $7.95 million

    Current assets

    $62.14M
    ALGS annual total current assets is $62.14 million

    Cash and cash equivalents

    $37.00M
    ALGS annual cash & cash equivalents is $37.00 million

    Accounts receivable

    -
    ALGS annual accounts receivable value is unknown

    Inventory

    $0.00
    ALGS annual inventory is $0.00

    Liabilities

    Total liabilities

    $100.82M
    ALGS annual total liabilities is $100.82 million

    Long term liabilities

    $77.33M
    ALGS annual total long term liabilities is $77.33 million

    Current liabilities

    $21.74M
    ALGS annual total current liabilities is $21.74 million

    Accounts payable

    $2.57M
    ALGS annual accounts payable is $2.57 million

    Debt

    Total debt

    $8.38M
    ALGS annual total debt is $8.38 million

    Total debt 1-year change

    -24.81%
    ALGS annual total debt is down -24.81% year-on-year

    Long term debt

    $4.92M
    ALGS annual long term debt is $4.92 million

    Short term debt

    $3.46M
    ALGS annual short term debt is $3.46 million

    Equity & Capital

    Shareholders equity

    -$28.97M
    ALGS annual stockholders equity is -$28.97 million

    Book value

    -$28.97M
    ALGS annual book value is -$28.97 million

    Retained earnings

    -$618.01M
    ALGS annual retained earnings is -$618.01 million

    Working capital

    $40.40M
    ALGS annual working capital is $40.40 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$80.74M
    ALGS annual cash flow from operations is -$80.74 million

    Cash from operations 1-year change

    -2.21%
    ALGS annual cash flow from operations is down -2.21% year-on-year

    Cash from investing

    -$18.28M
    ALGS annual cash flow from investing activities is -$18.28 million

    Cash from investing 1-year change

    -140.64%
    ALGS annual cash flow from investing activities is down -140.64% year-on-year

    Cash from financing

    $355.00K
    ALGS annual cash flow from financing activities is $355.00 thousand

    Cash from financing 1-year change

    -99.6%
    ALGS annual cash flow from financing activities is down -99.6% year-on-year

    CAPEX

    CAPEX

    $130.00K
    ALGS annual capital expenditures is $130.00 thousand

    CAPEX 1-year change

    +584.21%
    ALGS annual capital expenditures is up +584.21% year-on-year

    Free Cash Flow

    Free cash flow

    -$80.87M
    ALGS annual free cash flow is -$80.87 million

    Free cash flow 1-year change

    -2.35%
    ALGS annual free cash flow is down -2.35% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    33.54%
    ALGS annual gross profit margin is 33.54%

    Operating margin

    -2259.92%
    ALGS annual operating profit margin is -2259.92%

    Net margin

    -3326.01%
    ALGS annual net profit margin is -3326.01%

    ROA & ROE

    ROA

    -116.24%
    ALGS annual return on assets is -116.24%

    ROE

    -415.84%
    ALGS annual return on equity is -415.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ALGS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ALGS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.70
    ALGS price to book ratio is 0.70

    PB ratio Sector rank

    28.56%
    ALGS price to book ratio is higher than 28.56% of companies in Healthcare sector

    PS Ratio

    PS ratio

    22.34
    ALGS price to sales ratio is 22.34

    PS ratio Sector rank

    81.64%
    ALGS price to sales ratio is higher than 81.64% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$45.27M
    ALGS enterprise value is -$45.27 million

    Enterprise value Sector rank

    2.28%
    ALGS enterprise value is higher than 2.28% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.60
    ALGS EV/EBITDA is 0.60

    EV/EBITDA Sector rank

    71.8%
    ALGS EV/EBITDA is higher than 71.8% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.86
    ALGS annual current ratio is 2.86

    Quick ratio

    2.86
    ALGS annual quick ratio is 2.86

    Leverage

    Debt to equity

    -0.29
    ALGS annual debt to equity ratio is -0.29

    Interest coverage ratio

    -
    ALGS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    ALGS piotroski f-score is 3

    Altman Z-Score

    -14.98
    ALGS altman z-score is -14.98

    Analyst ratings

    Recent major analysts updates

    Mar 31, 25 HC Wainwright & Co.
    Buy
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Nov 7, 24 HC Wainwright & Co.
    Buy
    Oct 23, 24 HC Wainwright & Co.
    Buy
    Sep 20, 24 HC Wainwright & Co.
    Buy
    Aug 19, 24 HC Wainwright & Co.
    Buy
    Jan 17, 23 Piper Sandler
    Overweight
    Jan 6, 23 Piper Sandler
    Overweight
    Jan 6, 23 Jefferies
    Buy
    Nov 3, 22 SVB Leerink
    Market Perform

    Institutional Ownership

    Screeners with ALGS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Aligos Therapeutics, Inc.?
    • Does Aligos Therapeutics, Inc. pay dividends?
    • What sector is Aligos Therapeutics, Inc. in?
    • What industry is Aligos Therapeutics, Inc. in?
    • What country is Aligos Therapeutics, Inc. based in?
    • When did Aligos Therapeutics, Inc. go public?
    • Is Aligos Therapeutics, Inc. in the S&P 500?
    • Is Aligos Therapeutics, Inc. in the NASDAQ 100?
    • Is Aligos Therapeutics, Inc. in the Dow Jones?
    • When was Aligos Therapeutics, Inc.'s last earnings report?
    • When does Aligos Therapeutics, Inc. report earnings?

    What is the ticker symbol for Aligos Therapeutics, Inc.?

    The ticker symbol for Aligos Therapeutics, Inc. is NASDAQ:ALGS

    Does Aligos Therapeutics, Inc. pay dividends?

    No, Aligos Therapeutics, Inc. does not pay dividends

    What sector is Aligos Therapeutics, Inc. in?

    Aligos Therapeutics, Inc. is in the Healthcare sector

    What industry is Aligos Therapeutics, Inc. in?

    Aligos Therapeutics, Inc. is in the Biotechnology industry

    What country is Aligos Therapeutics, Inc. based in?

    Aligos Therapeutics, Inc. is headquartered in United States

    When did Aligos Therapeutics, Inc. go public?

    Aligos Therapeutics, Inc.'s initial public offering (IPO) was on October 16, 2020

    Is Aligos Therapeutics, Inc. in the S&P 500?

    No, Aligos Therapeutics, Inc. is not included in the S&P 500 index

    Is Aligos Therapeutics, Inc. in the NASDAQ 100?

    No, Aligos Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Aligos Therapeutics, Inc. in the Dow Jones?

    No, Aligos Therapeutics, Inc. is not included in the Dow Jones index

    When was Aligos Therapeutics, Inc.'s last earnings report?

    Aligos Therapeutics, Inc.'s most recent earnings report was on August 6, 2025

    When does Aligos Therapeutics, Inc. report earnings?

    The next expected earnings date for Aligos Therapeutics, Inc. is November 5, 2025
    On this page